熱門資訊> 正文
阿尔康因顶线失误下滑9%,更新2025年指引
2025-08-21 00:10
- Alcon (NYSE:ALC) is down ~9% in Wednesday trading after releasing Q2 financial results after Tuesday's closing bell that missed on the top line.
- In addition, the eye care company adjusted some of its 2025 guidance, including lowering net sales to $10.3B to $10.4B, down from $10.4B to $10.5B prior. Consensus is $10.47B.
- Core diluted EPS remained at $3.05 to $3.15. Consensus is $3.11.
- Q2 core diluted EPS of $0.76 compared to $0.74 in the year-ago period.
- While revenues in vision care -- Alcon's largest business unit -- increased 4% year over year, in surgical care, the increase was only 2%.
- Alcon ended the quarter with ~$1.4B in cash and cash equivalents compared to ~$1.7B on Dec. 31, 2024.
More on Alcon
- Alcon: More Than Meets The Eye
- Alcon's Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold'
- Alcon Non-GAAP EPS of $0.76 beats by $0.05, revenue of $2.58B misses by $60M
- Key deals this week: Walt Disney, Harrison Global, Alcon, Steelcase, Joby Aviation and more
- Seeking Alpha’s Quant Rating on Alcon
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。